# Pivotal Trial to Assess the Clinical Performance of Ophthal-360 for the Detection of Diabetic Retinopathy

> **NCT05806957** · — · UNKNOWN · sponsor: **Ophthalytics, Inc.** · enrollment: 500 (estimated)

## Conditions studied

- Diabetic Retinopathy

## Interventions

- **DEVICE:** Fundus Photography

## Key facts

- **NCT ID:** NCT05806957
- **Lead sponsor:** Ophthalytics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-01
- **Primary completion:** 2024-09-01
- **Final completion:** 2024-09-30
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2023-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05806957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05806957, "Pivotal Trial to Assess the Clinical Performance of Ophthal-360 for the Detection of Diabetic Retinopathy". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05806957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*